Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations

v3.22.2.2
Condensed Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Condensed Statements of Operations        
Revenue - related party $ 48 $ 29 $ 118 $ 252
Operating expenses:        
Research and development 8,866 9,384 35,589 20,795
General and administrative 1,846 1,923 6,218 6,410
Total operating expenses 10,712 11,307 41,807 27,205
Loss from operations (10,664) (11,278) (41,689) (26,953)
Other income        
Interest income 52 13 87 39
Total other income 52 13 87 39
Net Loss $ (10,612) $ (11,265) $ (41,602) $ (26,914)
Loss per Share:        
Basic net loss per common share outstanding $ (0.12) $ (0.14) $ (0.48) $ (0.36)
Diluted net loss per common share outstanding $ (0.12) $ (0.14) $ (0.48) $ (0.36)
Basic weighted average number of common shares outstanding 88,567,497 78,530,952 87,055,290 74,805,868
Diluted weighted average number of common shares outstanding 88,567,497 78,530,952 87,055,290 74,805,868